QUESTLAB Stock Overview
Engages in the manufacture and sale of pharmaceutical formulations in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Quest Laboratories Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹111.10 |
| 52 Week High | ₹196.80 |
| 52 Week Low | ₹85.10 |
| Beta | 0 |
| 11 Month Change | 24.83% |
| 3 Month Change | -14.54% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -24.60% |
Recent News & Updates
Quest Laboratories' (NSE:QUESTLAB) Solid Profits Have Weak Fundamentals
Nov 22
Not Many Are Piling Into Quest Laboratories Limited (NSE:QUESTLAB) Just Yet
Oct 22Shareholder Returns
| QUESTLAB | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -4.6% | 0.5% | 0.5% |
| 1Y | n/a | 42.5% | 27.5% |
Return vs Industry: Insufficient data to determine how QUESTLAB performed against the Indian Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how QUESTLAB performed against the Indian Market.
Price Volatility
| QUESTLAB volatility | |
|---|---|
| QUESTLAB Average Weekly Movement | 7.8% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: QUESTLAB's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: QUESTLAB's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 74 | Anil Sabarwal | questlabltd.com |
Quest Laboratories Limited engages in the manufacture and sale of pharmaceutical formulations in India. It offers ethical drugs, generic drugs, and over the-counter drugs under various categories, such as antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and others. The company provides its products in various forms, such as tablets, liquid orals, oral dry powders, oral powders, ointments, external liquids, and oral suspension.
Quest Laboratories Limited Fundamentals Summary
| QUESTLAB fundamental statistics | |
|---|---|
| Market cap | ₹1.82b |
| Earnings (TTM) | ₹117.83m |
| Revenue (TTM) | ₹841.71m |
15.5x
P/E Ratio2.2x
P/S RatioIs QUESTLAB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| QUESTLAB income statement (TTM) | |
|---|---|
| Revenue | ₹841.71m |
| Cost of Revenue | ₹504.39m |
| Gross Profit | ₹337.33m |
| Other Expenses | ₹219.50m |
| Earnings | ₹117.83m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.19 |
| Gross Margin | 40.08% |
| Net Profit Margin | 14.00% |
| Debt/Equity Ratio | 12.3% |
How did QUESTLAB perform over the long term?
See historical performance and comparison